Detalhe da pesquisa
1.
Can gadolinium compete with La-Fe-Co-Si in a thermomagnetic generator?
Sci Technol Adv Mater
; 22(1): 643-657, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34408552
2.
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications.
J Cell Mol Med
; 17(11): 1371-84, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24251854
3.
Romiplostim or standard of care in patients with immune thrombocytopenia.
N Engl J Med
; 363(20): 1889-99, 2010 Nov 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-21067381
4.
Phase 2 study of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving azacitidine therapy.
Blood
; 116(17): 3163-70, 2010 Oct 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-20631375
5.
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects.
Ann Hematol
; 89 Suppl 1: 75-85, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20155267
6.
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica
; 91(4): 546-9, 2006 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-16585019
7.
Successful treatment of cyclic thrombocytopenia with thrombopoietin-mimetic agents: a report of two patients.
Am J Hematol
; 84(7): 459-61, 2009 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-19484732
8.
Quantifying the reduction in immunoglobulin use over time in patients with chronic immune thrombocytopenic purpura receiving romiplostim (AMG 531).
Am J Hematol
; 84(8): 538-40, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19569197
9.
Randomized phase II study of palifermin for reducing dysphagia in patients receiving concurrent chemoradiotherapy for locally advanced unresectable non-small cell lung cancer.
J Thorac Oncol
; 7(1): 157-64, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22011667
10.
Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.
Cancer
; 117(5): 992-1000, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20945323
11.
Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial.
J Clin Oncol
; 29(20): 2815-20, 2011 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670447
12.
Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study.
J Clin Oncol
; 29(20): 2808-14, 2011 Jul 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21670453
13.
Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.
J Clin Oncol
; 28(3): 437-44, 2010 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20008626
14.
A phase II, open-label, sequential-cohort, dose-escalation study of romiplostim in Japanese patients with chronic immune thrombocytopenic purpura.
Int J Hematol
; 90(2): 157-165, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19543952
15.
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.
J Clin Oncol
; 26(15): 2489-96, 2008 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-18487568
16.
Comparative neurotoxicity of weekly non-break paclitaxel infusions over 1 versus 3 h.
Anticancer Drugs
; 14(10): 785-92, 2003 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-14597872
17.
Concise Manual of Hematology and Oncology
Berlin, Heidelberg; Springer Berlin Heidelberg;
2008.
Monografia
em Inglês
| Bibliografia | ID: bib-350531